BPC-157 Body Protection Compound-157

BPC-157 is a short chain of 15 amino acids (the basic building blocks of proteins) made entirely in a laboratory - it does not occur in nature. Studies in rodents have investigated how it interacts with tissue-repair processes, including tissue repair mechanisms, the growth of new blood vessels, and the protection of the stomach lining from experimentally induced damage.

BPC-157 is a synthetic pentadecapeptide — a chain of 15 amino acids (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) produced entirely through chemical synthesis. It does not occur naturally; the sequence was developed in a laboratory context as a stable partial sequence derived from gastric juice protein. Its structural stability across a range of experimental pH and temperature conditions makes it a practical tool for in vitro and preclinical cell-based studies.

Preclinical research has examined BPC-157 across several tissue-response systems. Rodent studies have investigated angiogenesis — the formation of new blood vessels into damaged or repairing tissue — and have looked at how the peptide interacts with vascular endothelial growth factor (VEGF) signalling pathways. Research has also explored its effects on the repair of musculoskeletal structures including tendons and ligaments, with studies examining cell migration and collagen organisation in damaged tissue models. Additionally, gastrointestinal research has investigated BPC-157’s interaction with the mucosal lining of the stomach and intestine in experimentally induced injury models.

BPC-157 is studied in the context of growth hormone receptor expression and nitric oxide pathway modulation. In cell culture studies, researchers have examined its influence on gene expression markers associated with tissue remodelling. It is frequently paired with TB-500 (Thymosin Beta-4) in multi-compound preclinical protocols, as the two peptides act on overlapping but distinct repair-associated pathways. Velox Peptides supplies BPC-157 as a lyophilised research reagent at 99.4% HPLC-verified purity for in vitro use. Not for human or veterinary consumption.

Summary paraphrased from the peer-reviewed preclinical literature. For in vitro research use only. For source citations, email support@veloxpeps.com.

Every batch of BPC-157 is third-party HPLC-tested prior to dispatch. Batch documentation is available on request.

Previous batch CoAs are archived in the CoA library. For batch-specific CoA requests prior to purchase, contact support@veloxpeps.com.

BPC-157 is sold by Velox Peptides (CRP Labs Ltd, UK company no. NI738125) and dispatched from the UK. Choose a vial size, pay on one page, and your order is dispatched the next working day.

• Delivery: Royal Mail Tracked 24 (1–2 working days, £5.99, free over £100) or Tracked 48 (2–3 working days, £3.80). See shipping.
• Payment: Pay by Bank through FCA-authorised open banking, or bank transfer. No card details needed.
• Testing: See the batch testing details above and past reports in the CoA library.
• Research use only: Supplied as a research reagent for in vitro use. Not for human or veterinary consumption. See our Research Use Policy.